
Bicycle Therapeutics (NASDAQ:BCYC) brought in sales totaling $3.77 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 22.88%, resulting in a loss of $18.04 million. In Q3, Bicycle Therapeutics brought in $4.33 million in sales but lost $14.68 million in earnings.